title: Benign form of atrophic papulosis developed at injection sites of pegylated-alpha-interferon: is there a pathophysiological link?
authors.affiliation: Department of Dermatology, Lyon 1 University - Centre Hospitalier Lyon Sud, 69495, PIERRE BENITE Cedex, France.
authors.forename: D
authors.initials: D
authors.lastname: Zaharia
authors.forename: F
authors.initials: F
authors.lastname: Truchot
authors.forename: S
authors.initials: S
authors.lastname: Ronger-Savle
authors.forename: B
authors.initials: B
authors.lastname: Balme
authors.forename: L
authors.initials: L
authors.lastname: Thomas
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D019698:Hepatitis C, Chronic / Q000188:drug therapy; D006801:Humans; D007271:Injections, Intradermal; D016898:Interferon-alpha / Q000009:adverse effects*; D008297:Male; D054853:Malignant Atrophic Papulosis / Q000139:chemically induced*
chemical_list: D000998:Antiviral Agents; D016898:Interferon-alpha